OXFD - Oxford Immunotec Global PLC

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5374.59M
Enterprise Value 3193.36M
Trailing P/E 2.89
Forward P/E 1-117.25
PEG Ratio (5 yr expected) 1482.33
Price/Sales (ttm)5.96
Price/Book (mrq)1.73
Enterprise Value/Revenue 33.08
Enterprise Value/EBITDA 6-16.18

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 206.18%
Operating Margin (ttm)-21.86%

Management Effectiveness

Return on Assets (ttm)-4.58%
Return on Equity (ttm)12.98%

Income Statement

Revenue (ttm)62.86M
Revenue Per Share (ttm)2.40
Quarterly Revenue Growth (yoy)26.60%
Gross Profit (ttm)42.93M
EBITDA -11.95M
Net Income Avi to Common (ttm)19.2M
Diluted EPS (ttm)4.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)189.52M
Total Cash Per Share (mrq)7.12
Total Debt (mrq)8.3M
Total Debt/Equity (mrq)3.84
Current Ratio (mrq)12.60
Book Value Per Share (mrq)8.12

Cash Flow Statement

Operating Cash Flow (ttm)-11.03M
Levered Free Cash Flow (ttm)-5.58M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.62
52-Week Change 31.68%
S&P500 52-Week Change 34.25%
52 Week High 319.19
52 Week Low 311.66
50-Day Moving Average 315.32
200-Day Moving Average 315.41

Share Statistics

Avg Vol (3 month) 3143.22k
Avg Vol (10 day) 3150.57k
Shares Outstanding 526.62M
Float 21.02M
% Held by Insiders 12.83%
% Held by Institutions 190.31%
Shares Short (May 31, 2019) 4696.74k
Short Ratio (May 31, 2019) 43.78
Short % of Float (May 31, 2019) 42.96%
Short % of Shares Outstanding (May 31, 2019) 42.62%
Shares Short (prior month Apr 30, 2019) 4440.29k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A